Yeshwant Krishna — SEC Form 4 filings

SEC reporting owner CIK 1585001. 4 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-06-28 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Verve Therapeutics, Inc. (VERV)Director, 10% owner37
Parabilis Medicines, Inc. (PBLS)Director11

Form 4 filings — Yeshwant Krishna

FiledFormIssuerReported transactionsSource
2026-06-114Parabilis Medicines, Inc. (PBLS)Grant/award (A): 20,215 (derivative) @ $0EDGAR
2025-07-284Verve Therapeutics, Inc. (VERV)Code (U): 6,108,442 · Code (U): 4,260,047 · Code (U): 1,800,000 · Disposition to issuer (D): 136,139 (derivative) · Disposition to issuer (D): 42,200 (derivative)EDGAR
2025-06-064Verve Therapeutics, Inc. (VERV)Grant/award (A): 42,200 (derivative) @ $0EDGAR
2024-06-284Verve Therapeutics, Inc. (VERV)Grant/award (A): 136,139 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1585001 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →